Myles Taylor Medical Services Limited - Period Ending 2020-06-30

Myles Taylor Medical Services Limited - Period Ending 2020-06-30


Myles Taylor Medical Services Limited 09084894 false 2019-07-01 2020-06-30 2020-06-30 The principal activity of the company is the provision of medical services. Digita Accounts Production Advanced 6.29.9459.0 true true 09084894 2019-07-01 2020-06-30 09084894 2020-06-30 09084894 bus:Director1 1 2020-06-30 09084894 bus:OrdinaryShareClass1 bus:CumulativeShares 2020-06-30 09084894 bus:OrdinaryShareClass2 bus:CumulativeShares 2020-06-30 09084894 core:RetainedEarningsAccumulatedLosses 2020-06-30 09084894 core:ShareCapital 2020-06-30 09084894 core:CurrentFinancialInstruments 2020-06-30 09084894 core:CurrentFinancialInstruments core:WithinOneYear 2020-06-30 09084894 core:FurnitureFittingsToolsEquipment 2020-06-30 09084894 bus:SmallEntities 2019-07-01 2020-06-30 09084894 bus:AuditExemptWithAccountantsReport 2019-07-01 2020-06-30 09084894 bus:FullAccounts 2019-07-01 2020-06-30 09084894 bus:SmallCompaniesRegimeForAccounts 2019-07-01 2020-06-30 09084894 bus:RegisteredOffice 2019-07-01 2020-06-30 09084894 bus:Director1 2019-07-01 2020-06-30 09084894 bus:Director1 1 2019-07-01 2020-06-30 09084894 bus:Director2 2019-07-01 2020-06-30 09084894 bus:OrdinaryShareClass1 bus:CumulativeShares 2019-07-01 2020-06-30 09084894 bus:OrdinaryShareClass2 bus:CumulativeShares 2019-07-01 2020-06-30 09084894 bus:PrivateLimitedCompanyLtd 2019-07-01 2020-06-30 09084894 core:FurnitureFittingsToolsEquipment 2019-07-01 2020-06-30 09084894 core:OfficeEquipment 2019-07-01 2020-06-30 09084894 countries:AllCountries 2019-07-01 2020-06-30 09084894 2019-06-30 09084894 core:FurnitureFittingsToolsEquipment 2019-06-30 09084894 2018-07-01 2019-06-30 09084894 2019-06-30 09084894 bus:Director1 1 2019-06-30 09084894 bus:OrdinaryShareClass1 bus:CumulativeShares 2019-06-30 09084894 bus:OrdinaryShareClass2 bus:CumulativeShares 2019-06-30 09084894 core:RetainedEarningsAccumulatedLosses core:RestatedAmount 2019-06-30 09084894 core:ShareCapital 2019-06-30 09084894 core:CurrentFinancialInstruments 2019-06-30 09084894 core:CurrentFinancialInstruments core:WithinOneYear core:RestatedAmount 2019-06-30 09084894 core:FurnitureFittingsToolsEquipment 2019-06-30 09084894 core:RestatedAmount 2019-06-30 09084894 bus:Director1 1 2018-07-01 2019-06-30 iso4217:GBP xbrli:pure xbrli:shares

Myles Taylor Medical Services Limited

Annual Report and Unaudited Financial Statements
Year Ended 30 June 2020

Registration number: 09084894

 

Myles Taylor Medical Services Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Myles Taylor Medical Services Limited

Company Information

Directors

Mr M J O Taylor

Mrs A H Taylor

Registered office

Centenary House
Peninsula Park
Rydon Lane
Exeter
Devon
EX2 7XE

Accountants

PKF Francis Clark
Centenary House
Peninsula Park
Rydon Lane
Exeter
Devon
EX2 7XE

 

Myles Taylor Medical Services Limited

Balance Sheet

30 June 2020

Note

2020
£

(As restated)

2019
£

Fixed assets

 

Tangible assets

4

2,466

856

Current assets

 

Debtors

5

213,161

192,634

Cash at bank and in hand

 

176,849

185,305

 

390,010

377,939

Creditors: Amounts falling due within one year

6

(38,922)

(153,086)

Net current assets

 

351,088

224,853

Total assets less current liabilities

 

353,554

225,709

Provisions for liabilities

(470)

(163)

Net assets

 

353,084

225,546

Capital and reserves

 

Called up share capital

7

100

100

Profit and loss account

352,984

225,446

Shareholders' funds

 

353,084

225,546

 

Myles Taylor Medical Services Limited

Balance Sheet

30 June 2020

For the financial year ending 30 June 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 3 June 2021 and signed on its behalf by:
 

.........................................
Mr M J O Taylor
Director

   
     

Company Registration Number: 09084894

 

Myles Taylor Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 June 2020

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Centenary House
Peninsula Park
Rydon Lane
Exeter
Devon
EX2 7XE

The principal place of business is:
Webberton House
2 Belvedere Park
Dunchideock
EX2 9TY

These financial statements were authorised for issue by the Board on 3 June 2021.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. There are no material departures from FRS102.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The directors of Myles Taylor Medical Services Limited have considered the impact of COVID-19.

In the opinion of the directors, the company has sufficient working capital within existing facilities to continue to trade for the foreseeable future, and therefore the financial statements have been prepared on a going concern basis.

 

Myles Taylor Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 June 2020

Prior period adjustments

During the year ended 30 June 2020 it was identified that the company should have previously registered for VAT. An adjustment for the VAT relating to the accounts for the year ended 30 June 2019 was processed through those accounts as they had not yet been finalised at this point, however, the adjustment to VAT for periods prior to this was not reflected through the comparatives or the brought forward profit and loss reserves. A prior period adjustment has therefore been done this year to correct the profit and loss reserve brought forward as at 1 July 2018. This resulted in a reduction in the reserves of £88,210.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on all timing differences at the balance sheet date unless indicated below. Timing differences are differences between taxable profits and the results as stated in the profit and loss account and other comprehensive income. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

25% straight line

 

Myles Taylor Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 June 2020

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
The company holds the following financial instruments:

• Short term trade and other debtors and creditors;
• Cash and bank balances.

All financial instruments are classified as basic.

 Recognition and measurement
The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.


 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2019 - 1).

 

Myles Taylor Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 June 2020

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 July 2019

1,142

1,142

Additions

2,460

2,460

At 30 June 2020

3,602

3,602

Depreciation

At 1 July 2019

286

286

Charge for the year

850

850

At 30 June 2020

1,136

1,136

Carrying amount

At 30 June 2020

2,466

2,466

At 30 June 2019

856

856

5

Debtors

2020
£

2019
£

Trade debtors

195,619

166,818

Prepayments

876

1,312

Other debtors

16,666

24,504

213,161

192,634

 

Myles Taylor Medical Services Limited

Notes to the Unaudited Financial Statements

Year Ended 30 June 2020

6

Creditors

Creditors: amounts falling due within one year

2020
£

(As restated)

2019
£

Due within one year

Trade creditors

414

2,053

Taxation and social security

6,596

122,960

Corporation tax

17,091

26,500

Accruals and deferred income

14,821

1,573

38,922

153,086

7

Share capital

Allotted, called up and fully paid shares

 

2020

2019

 

No.

£

No.

£

Ordinary A shares of £1 each

80

80

80

80

Ordinary B shares of £1 each

20

20

20

20

 

100

100

100

100

8

Related party transactions

Advances to directors

2020

At 1 July 2019
£

Advances to director
£

Repayments by director
£

At 30 June 2020
£

Directors' loan account

Loan account charged at HMRC's official rate

24,504

30,517

(38,355)

16,666

         
         

 

2019

At 1 July 2018
£

Advances to director
£

Repayments by director
£

At 30 June 2019
£

Directors' loan account

Loan account charged at HMRC's official rate

18,552

40,565

(34,613)

24,504